glp-1 drug exposure pharmaceutical companies 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Market Trends and Global

Younger consumers, particularly millennials and Gen Z, are driving adoption of anti-aging treatments, immune-supporting supplements, and detoxification products as part of comprehensive wellness strategies, while simultaneously, aging populations are seeking preventive solutions to address chronic disease risk and age-related decline

Brand-name options cost $1,000-1,400 monthly

Speed and efficiency of NMN uptake Studies show NMN absorbs and converts quickly

Helps by calming glutamate-related brain overactivity

Also, peptides in oral supplements are digested just like your food, so they don't enter your bloodstream intact

Despite the high prevalence and the potential adverse impact on quality of life, there are currently no FDA-approved drugs specifically for treatment of tinnitus